Brown Appoints Psilocybin Board, Local Doc. Tapped

On Tuesday, Oregon Governor Kate Brown announced the members of the Oregon Psilocybin Advisory Board, which includes Licensed Psychologist Dr. Kimberley Golletz, who practices in Corvallis. This is the first program nationwide to allow the regulated and therapeutic use of psilocybin. 

The board, which includes doctors, researchers, therapists and fungi experts, among others, will collaborate for the framework of the program that was outlined in Measure 109 and voters approved in November.  

“Like many, I was initially skeptical when I first heard of Measure 109,” said Brown in a press release. “But if we can help people suffering from PTSD, depression, trauma and addiction — including veterans, cancer patients, and others — supervised psilocybin therapy is a treatment worthy of further consideration.” 

Measure 109 allowed a two-year implementation process that will begin on March 31 when the board meets. The press release also says that Brown’s recommend budget for 2021-2023 includes $5.6 million to implement the measure.  

The board is going to be creating a system where people who are both 21 or older and have passed a screening can experience psychedelic mushrooms. They also will figure out how to license the storing and administration of the substance that is illegal nationally. 

The possession of small amounts psilocybin and other drugs was decriminalized in November when Oregon voters approved Measure 110. 

The Members of Oregon Psilocybin Advisory Board are: 

Public Health Director Designee: Andre Ourso, OHA 

State Health Officer Designee: Dr. Tom Jeanne, OHA 

Oregon Health Policy Board Designee: Barb Hansen 

State Employee w/ Public Health Expertise: Ali Hamade, OHA 

Local Health Officer: Dr. Sarah Present, Clackamas City 

Addictions Medicine Specialist: Kevin Fitts, Portland 

Licensed Psychologist: Dr. Kimberley Golletz, Corvallis 

Licensed Physician: Dr. Todd Korthius, OHSU 

Academic Researcher: Dr. Mason Marks, Portland 

Mycologist: Jessie Uehling, Oregon State University 

Harm Reduction Specialist: Angela Carter, Portland 

Psychopharmacologic Specialist: Dr. Atheir Abbas, OHSU 

OLCC: Nathan Rix 

Oregon DOJ: David Hart 

Chief Petitioner Designee: Tom Eckert 

Public: Stephanie Barrs, Bend 

Public: Dr. Rachel Knox, Portland  

By: Hannah Ramsey